Cargando…
Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial
INTRODUCTION: Patient compliance with oral nutritional supplements (ONS) is not optimal for meeting energy and nutritional requirements in a high proportion of patients with disease-related malnutrition (DRM). Energy density or prescribed volume of ONS may impact compliance. METHODS: A randomized, o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186345/ https://www.ncbi.nlm.nih.gov/pubmed/37200944 http://dx.doi.org/10.3389/fnut.2023.1182445 |
_version_ | 1785042539889295360 |
---|---|
author | Leon-Sanz, Miguel Linares, Francisca Gonzalo, Montserrat Tapia, María José Maiz-Jimenez, María Ruiz Aguado, Marta Lizán, Luis Olveira, Gabriel |
author_facet | Leon-Sanz, Miguel Linares, Francisca Gonzalo, Montserrat Tapia, María José Maiz-Jimenez, María Ruiz Aguado, Marta Lizán, Luis Olveira, Gabriel |
author_sort | Leon-Sanz, Miguel |
collection | PubMed |
description | INTRODUCTION: Patient compliance with oral nutritional supplements (ONS) is not optimal for meeting energy and nutritional requirements in a high proportion of patients with disease-related malnutrition (DRM). Energy density or prescribed volume of ONS may impact compliance. METHODS: A randomized, open-label crossover trial was conducted in outpatients with DRM to compare compliance with a high energy-dense ONS (edONS, 2.4 kcal/mL) and a reference ONS (heONS, 2.0 kcal/mL; NCT05609006). Patients were randomly assigned to two 8-week treatment sequences of four-weeks periods: edONS + heONS (sequence A) or heONS + edONS (sequence B). Patients daily reported the amount of product left over gastrointestinal tolerance and satisfaction with ONS. A non-inferiority analysis was performed to compare the compliance rate (percentage of consumed energy over the prescribed) for each period and sequence. RESULTS: Fifty-three patients were assigned to sequence A and 50 to sequence B (55.7 ± 13.9 years, 37.0% female, 67.1% oncology patients). In sequence A, the compliance rates were 88.6% ± 14.3% vs. 84.1 ± 21.8% (p = 0.183), while in sequence B, they were 78.9% ± 23.8% vs. 84.4% ± 21.4% (p < 0.01). In both sequences, the lower range of the confidence interval for compliance with edONS was greater than the non-inferiority threshold (for sequence A Δ(Comp)(A) was 4.5% [95% CI, −2.0% to 10.0%], and for sequence, B Δ(Comp)(B) was 5.6% [95% CI, −3.0% to 14.0%]). The total discarded cost for each ONS was higher for heONS than edONS, being the difference statistically significant in sequence B. BMI increased slightly and not significantly in both sequences, and the percentage of patients with severe malnutrition was reduced. The frequency of gastrointestinal symptoms was low for both sequences, and satisfaction with ONS was slightly higher for edONS. CONCLUSION: Our findings highlight that edONS was non-inferior to heONS in terms of consumed energy over the prescribed, with a lower amount of edONS discarded, which suggests a higher efficiency of edONS. |
format | Online Article Text |
id | pubmed-10186345 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101863452023-05-17 Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial Leon-Sanz, Miguel Linares, Francisca Gonzalo, Montserrat Tapia, María José Maiz-Jimenez, María Ruiz Aguado, Marta Lizán, Luis Olveira, Gabriel Front Nutr Nutrition INTRODUCTION: Patient compliance with oral nutritional supplements (ONS) is not optimal for meeting energy and nutritional requirements in a high proportion of patients with disease-related malnutrition (DRM). Energy density or prescribed volume of ONS may impact compliance. METHODS: A randomized, open-label crossover trial was conducted in outpatients with DRM to compare compliance with a high energy-dense ONS (edONS, 2.4 kcal/mL) and a reference ONS (heONS, 2.0 kcal/mL; NCT05609006). Patients were randomly assigned to two 8-week treatment sequences of four-weeks periods: edONS + heONS (sequence A) or heONS + edONS (sequence B). Patients daily reported the amount of product left over gastrointestinal tolerance and satisfaction with ONS. A non-inferiority analysis was performed to compare the compliance rate (percentage of consumed energy over the prescribed) for each period and sequence. RESULTS: Fifty-three patients were assigned to sequence A and 50 to sequence B (55.7 ± 13.9 years, 37.0% female, 67.1% oncology patients). In sequence A, the compliance rates were 88.6% ± 14.3% vs. 84.1 ± 21.8% (p = 0.183), while in sequence B, they were 78.9% ± 23.8% vs. 84.4% ± 21.4% (p < 0.01). In both sequences, the lower range of the confidence interval for compliance with edONS was greater than the non-inferiority threshold (for sequence A Δ(Comp)(A) was 4.5% [95% CI, −2.0% to 10.0%], and for sequence, B Δ(Comp)(B) was 5.6% [95% CI, −3.0% to 14.0%]). The total discarded cost for each ONS was higher for heONS than edONS, being the difference statistically significant in sequence B. BMI increased slightly and not significantly in both sequences, and the percentage of patients with severe malnutrition was reduced. The frequency of gastrointestinal symptoms was low for both sequences, and satisfaction with ONS was slightly higher for edONS. CONCLUSION: Our findings highlight that edONS was non-inferior to heONS in terms of consumed energy over the prescribed, with a lower amount of edONS discarded, which suggests a higher efficiency of edONS. Frontiers Media S.A. 2023-05-02 /pmc/articles/PMC10186345/ /pubmed/37200944 http://dx.doi.org/10.3389/fnut.2023.1182445 Text en Copyright © 2023 Leon-Sanz, Linares, Gonzalo, Tapia, Maiz-Jimenez, Ruiz Aguado, Lizán and Olveira. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Leon-Sanz, Miguel Linares, Francisca Gonzalo, Montserrat Tapia, María José Maiz-Jimenez, María Ruiz Aguado, Marta Lizán, Luis Olveira, Gabriel Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial |
title | Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial |
title_full | Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial |
title_fullStr | Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial |
title_full_unstemmed | Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial |
title_short | Compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial |
title_sort | compliance with a high-protein and energy-dense oral nutritional supplement in patients with disease-related malnutrition: a randomized open-label crossover trial |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186345/ https://www.ncbi.nlm.nih.gov/pubmed/37200944 http://dx.doi.org/10.3389/fnut.2023.1182445 |
work_keys_str_mv | AT leonsanzmiguel compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial AT linaresfrancisca compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial AT gonzalomontserrat compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial AT tapiamariajose compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial AT maizjimenezmaria compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial AT ruizaguadomarta compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial AT lizanluis compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial AT olveiragabriel compliancewithahighproteinandenergydenseoralnutritionalsupplementinpatientswithdiseaserelatedmalnutritionarandomizedopenlabelcrossovertrial |